230.69

1.49% -3.49

Pre-market: 230.98 0.29 +0.13%

Johnson Johnson (JNJ)

Overview News Price History Option Chain Financials Why JNJ Down? Discussions Forecast Stock Split Dividend History

Johnson Johnson stock is traded at $230.69, with a volume of 7.75M. It is down -1.49% in the last 24 hours and down -1.99% over the past month. Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Previous Close:

$234.18

Open:

$234.81

24h Volume:

7.75M

Relative Volume:

0.90

Market Cap:

$555.64B

Revenue:

$96.36B

Net Income/Loss:

$21.04B

P/E Ratio:

26.67

EPS:

8.6488

Net Cash Flow:

$19.70B

1W Performance:

-3.06%

1M Performance:

-1.99%

6M Performance:

+19.08%

1Y Performance:

+46.50%

1-Day Range:

$229.53

$235.26

1-Week Range:

$229.53

$242.19

52-Week Range:

$146.12

$251.71

Johnson Johnson Stock (JNJ) Company Profile

Name

Johnson Johnson

Sector

Healthcare (1114)

Industry

Drug Manufacturers - General (20)

Phone

732-524-2455

Address

ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ

Employee

140,800

Twitter

@jnjnews

Next Earnings Date

2026-04-14

Latest SEC Filings

JNJ's Discussions on Twitter

Compare JNJ vs LLY, ABBV, AZN, MRK

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
JNJ Johnson Johnson	230.69	564.05B	96.36B	21.04B	19.70B	8.6488
LLY Lilly Eli Co	919.90	828.17B	65.18B	20.64B	5.96B	22.59
ABBV Abbvie Inc	203.71	368.57B	61.16B	4.19B	17.82B	2.3614
AZN Astrazeneca Plc	200.69	317.61B	58.80B	10.24B	8.98B	3.2788
MRK Merck Co Inc	117.10	294.09B	64.93B	18.26B	12.36B	7.2751

Johnson Johnson Stock (JNJ) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-08-26	Resumed	TD Cowen	Buy
Jan-28-26	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-13-25	Initiated	Scotiabank	Sector Outperform
Oct-20-25	Upgrade	Daiwa Securities	Neutral → Outperform
Oct-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight
Sep-23-25	Upgrade	Guggenheim	Neutral → Buy
Jul-23-25	Upgrade	Erste Group	Hold → Buy
May-13-25	Downgrade	Leerink Partners	Outperform → Market Perform
Dec-10-24	Resumed	BofA Securities	Neutral
Nov-15-24	Initiated	Wolfe Research	Outperform
Jul-23-24	Downgrade	Daiwa Securities	Outperform → Neutral
May-30-24	Resumed	Goldman	Neutral
Apr-18-24	Upgrade	HSBC Securities	Hold → Buy
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Dec-01-23	Upgrade	UBS	Neutral → Buy
Oct-05-23	Initiated	RBC Capital Mkts	Outperform
Sep-06-23	Initiated	HSBC Securities	Hold
May-30-23	Resumed	Citigroup	Buy
Mar-29-23	Initiated	UBS	Neutral
Mar-01-23	Initiated	Guggenheim	Neutral
Nov-18-22	Initiated	Credit Suisse	Neutral
Oct-18-22	Initiated	Barclays	Equal Weight
Oct-14-22	Reiterated	BofA Securities	Neutral
Jun-22-22	Initiated	Daiwa Securities	Outperform
May-23-22	Resumed	SVB Leerink	Outperform
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight
Mar-16-22	Downgrade	Bernstein	Outperform → Mkt Perform
Mar-02-22	Resumed	BofA Securities	Neutral
Dec-17-21	Initiated	Goldman	Neutral
Dec-15-21	Reiterated	Citigroup	Buy
Sep-07-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
May-28-21	Resumed	Morgan Stanley	Overweight
Apr-28-20	Downgrade	UBS	Buy → Neutral
Apr-22-20	Upgrade	BofA/Merrill	Neutral → Buy
Mar-05-20	Initiated	Citigroup	Buy
Dec-19-19	Upgrade	Barclays	Equal Weight → Overweight
Dec-17-19	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-20-19	Initiated	Cantor Fitzgerald	Overweight
Oct-16-19	Upgrade	Atlantic Equities	Underweight → Neutral
Oct-11-19	Upgrade	Bernstein	Mkt Perform → Outperform
Jul-12-19	Resumed	Credit Suisse	Outperform
May-28-19	Initiated	Goldman	Buy
Jan-23-19	Reiterated	Barclays	Equal Weight
Jul-12-18	Upgrade	Goldman	Sell → Neutral
Jun-27-18	Initiated	Bernstein	Mkt Perform
Apr-23-18	Reiterated	Citigroup	Neutral
Apr-18-18	Reiterated	Stifel	Hold
Jan-24-18	Reiterated	Stifel	Hold
Jan-12-18	Reiterated	Wells Fargo	Outperform
Jan-02-18	Downgrade	JP Morgan	Overweight → Neutral
Oct-18-17	Reiterated	RBC Capital Mkts	Outperform
Oct-18-17	Reiterated	Stifel	Hold

View All

Johnson Johnson Stock (JNJ) Latest News

12:34 PM

Judge clears Fitz Johnson to remain on ballot in Georgia residency dispute - Georgia Recorder

12:34 PM

12:30 PM

[Latest] Global Surgical Drill Bits Market Size/Share Worth USD 540 Million by 2035 at a 5.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.

12:30 PM

Apr 20, 2026

Guggenheim Raises Johnson & Johnson (JNJ) Target on Icotyde Upside, Keeps Buy Rating - Yahoo Finance

Apr 20, 2026